Q-Line Biotech IPO Allotment Status: Check Online on Registrar & NSE SME

As on 25 May 2026, 5PM, 05:00 PM IST, the allotment for the Q-Line Biotech IPO of ₹214.48 crores is expected to be finalized on 26 May 2026. Investors can check the allotment status through Purva Sharegistry (India) Private Limited or on the NSE SME website using their PAN number or application number.

The subscription for the Q-Line Biotech IPO closed on 25 May 2026. The IPO was open for bidding from 21 May 2026 to 25 May 2026 and was priced in the range of ₹326 to ₹343 per share. The total issue size was ₹214.48.

Shares are expected to be credited to investors’ demat accounts on , while the IPO is scheduled to list on NSE SME on 29 May 2026.

How to check Q-Line Biotech IPO Allotment Status on Registrar site

Step 1: Visit Purva Sharegistry (India) Private Limited
Step 2: Select Q-Line Biotech from the drop-down menu on the page
Step 3: Enter details required like PAN Card, Application Number, or Demat Account Number
Step 4: Click on the ‘Submit’ Button and view your allotment status

How to check Q-Line Biotech IPO Allotment Status on NSE website

Step 1: Go to Status of Issue Application Page on NSE Website
Step 2: Select “Equity & SME IPO bid details”
Step 3: Select IPO Company Code QLINE from the Dropdown
Step 4: Enter your PAN & Application Number in the required field
Step 5: Click on “Submit” Button and view your allotment status

What happens if you get the Q-Line Biotech IPO allotment?

If you get Q-Line Biotech IPO allotment, the company’s shares will be credited to your demat account on [-], based on your allotment. Once the shares are credited, the amount blocked in your bank account will be debited accordingly.

After the IPO is listed on 29 May 2026 on the NSE SME, you may choose to either hold the shares as a long-term investment or sell them in the market.

What if you didn’t get the Q-Line Biotech IPO allotment?

If you didn’t receive allotment of Q-Line Biotech IPO:
• Refunds will be initiated on or about 27 May 2026.
• The amount will be credited to your bank account linked to UPI On the other hand, if allotted shares will reflect in your Demat by 27 May 2026
• After the listing date, you can continue to track and invest in the stock directly through Kotak Neo

About Q-Line Biotech

QLine Biotech Limited was originally incorporated as POCT Services Private Limited on November 10, 2010 as a Private limited company dated November 10, 2010 issued by the Assistant Registrar of Companies, Uttar Pradesh and Uttarakhand. Subsequently, the name of Company was changed to QLine Biotech Private Limited on July 23, 2021. Further, Company was converted from a private company to public company andthe name of Company was changed to QLine Biotech Limited, via fresh certificate of incorporation dated March 08, 2025 issued by Central Processing Centre.The Company is engaged in the business of developing, manufacturing and marketing of diverse range of reagents (including kits and POC devices) consumables and manufacturing, importing, distribution/supply of diagnostic equipment for different diagnostic healthcare needs. Company supplies diagnostic equipment and IVD products for different diagnostic healthcare needs since 2013 directly or through its distributors majorly to diagnostic service providers, hospitals and medical colleges. The core segments of operations of the Company in IVD Industry include Clinical Chemistry, Haematology, Immunodiagnostics, Molecular Diagnostics and Others (POC Devices Rapids).The Company established first manufacturing plant at Bawana, New Delhi in 201617. Further, during the year 2019, it incorporated POCT Science House Private Limited to engage in the business of running diagnostic laboratories. Since 2021, the facilities have been subject to regular inspections and audits by regulators, including the CDSCO, State Drug Authority, Intertek, URS Certification Limited, and other European regulatory agencies, conducted on a periodic basis. As a part of growth strategy, Company incorporated subsidiary companies namely QLine Iris Private Limited which are engaged in the business of Radiology Imaging Services, which was established in the year 2023. However, during the financial year 2025, Company has sold the controlling stake in QLine Nutraceuticals Private Limited to focus on the core business. The Company has acquired a manufacturing plant at Lucknow, Uttar Pradesh in 2025. Company is planning a fresh issue IPO of 70,53,200 equity shares of Rs 10 each.